Skip to main content

Advertisement

Table 1 Demographic and baseline characteristics of patients with DR-TB treated with IFN gamma

From: Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study

Patient 1 2 3 4 5 6 7 8
Age (years) 28 50 54 27 44 50 23 37
Sex Male Male Female Female Male Male Female Male
Race Mestizo White Mestizo Mestizo White Mestizo Black Black
BMI (Kg/m 2 ) 19.6 18.9 13.2 18.3 14.6 21.6 22.0 17.1
Sputum smear status* 0 9 9 9 8 9 8 9
Sputum culture status** 7 9 7 9 6 9 8 9
Drug Resistance INH
RIF
STR
INH
STR
INH
RIF
STR
INH
RIF
INH, STR INH
RIF
STR
INH INH
Initial thorax X-ray R1 R2 R3 R4 R5 R6 R7 R8
GSR (mm/h) 5 66 53 53 68 101 10 60
  1. INH: Isoniazid; RIF: Rifampin; STR: Streptomycin; ETB: Ethambutol; ETN: Ethionamide; PRZ: Pyrazinamide; CPF: Ciprofloxacin; KAN: Kanamycin; AMK: Amikacin.
  2. * Number of bacilli; 0: 0 in 4 lines; 8: 25 or more in 1 line; 9: bacilli in most of the fields.
  3. ** Number of colonies; 6: 6–24 colonies; 7: 25–100 colonies; 9: confluent growth.
  4. R1 and R3. Extensive bilateral exudative lesions
  5. R2: Moderate exudative lesions
  6. R4: Left fibro-exudative lesions
  7. R5: Moderate Bilateral fibro-exudative lesions.
  8. R6: Cavitary lesions at superior lobes; fibrous lesions at right superior lobe; alveolar infiltrate at left superior lobe.
  9. R7 and R8: Very diffuse fibromatous lesions at superior lobes.